Anti-Choline Acetyltransferase antibody [EPR13024(B)]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
4
(1 Review)
|
(46 Publications)
Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) is a rabbit monoclonal antibody detecting Choline Acetyltransferase in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, IHC-P, IHC-Fr, ICC/IF. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 20 publications
View Alternative Names
Choline O-acetyltransferase, CHOACTase, ChAT, Choline acetylase, CHAT
- IHC-Fr
Lab
Immunohistochemistry (Frozen sections) - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
IHC image of Choline Acetyltransferase staining in a section of frozen normal human cerebral cortex performed on a Leica BONDTM system using the standard protocol. The section was fixed in 10% paraformaldehyde (10 min) prior to staining. The section was incubated with ab181023, 1/2000 dilution, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Intracellular Flow Cytometry analysis of SH-SY5Y cells labeling Choline Acetyltransferase using ab181023 (unpurified) at a 1/110 dilution (pink). Goat anti rabbit IgG (FITC) used as the secondary at a 1/150 dilution. Isotype control Rabbit monoclonal IgG (green). Cells were fixed in 2% paraformaldehyde.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human cerebrum tissue sections labeling Choline Acetyltransferase with purified ab181023 at 1/2000 dilution (0.28 μg/ml). Heat mediated antigen retrieval was performed using heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Immunocytochemistry/ Immunofluorescence analysis of U-87 MG (Human glioblastoma-astrocytoma epithelial cell) cells labeling Choline Acetyltransferase with purified ab181023 at 1/50 dilution (10 μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) at 1 : 200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Immunofluorescent analysis of 4% paraformaldehyde fixed SH-SY5Y cells labeling Choline Acetyltransferase using ab181023 (unpurified) at a 1/100 dilution. A Goat anti rabbit IgG (Alexa Fluor®555) was used as the secondary at a 1/100 dilution.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Intracellular Flow Cytometry analysis of SH-SY5Y (Human neuroblastoma epithelial cell) cells labeling Choline Acetyltransferase with purified ab181023 at 1/60 dilution (10μg/ml) (red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IP
Unknown
Immunoprecipitation - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
ab181023 (purified) at 1/30 dilution (2ug) immunoprecipitating Choline Acetyltransferase in Human fetal brain lysate. Human fetal brain lysate 10ug
Lane 2 (+) : ab181023 & Human fetal brain lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab181023 in Human fetal brain lysate
For western blotting, VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023)
Predicted band size: 82 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Lysate from Human fetal brain (Lane 1) and negative control (Lane 2) were immunoprecipitated with ab181023 (unpurified) at a 1/70 dilution. A anti-rabbit IgG (HRP), specific to the non-reduced form of IgG at a 1/1500 dilution for the secondary. Blocking/ Dilution buffer : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023)
Predicted band size: 82 kDa
false
- WB
Supplier Data
Western blot - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
Blocking/ Dilution buffer : 5% NFDM /TBST.
All lanes:
Western blot - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) at 1/5000 dilution
Lane 1:
SH-SY5Y cell lysate at 20 µg
Lane 2:
Human fetal brain lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 82 kDa
false
- WB
Lab
Western blot - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (AB181023)
This antibody recognizes all Choline Acetyltransferase isoforms with the MW ranging from 70-82 KDa based on immunogen blast.
All lanes:
Western blot - Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) at 1/2000 dilution
Lane 1:
SH-SY5Y (Human neuroblastoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
Mouse brain lysates at 20 µg
Lane 3:
Rat brain lysates at 20 µg
Lane 4:
C6 (Rat glial tumor glial cell) whole cell lysates at 20 µg
Lane 5:
Human fetal brain lysates at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 82 kDa
Observed band size: 70-82 kDa
false
Related conjugates and formulations (6)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Choline Acetyltransferase antibody [EPR13024(B)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Choline Acetyltransferase antibody [EPR13024(B)]
-
660 APC
APC Anti-Choline Acetyltransferase antibody [EPR13024(B)]
-
Anti-Choline Acetyltransferase antibody [EPR13024(B)] - BSA and Azide free
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Choline Acetyltransferase antibody [EPR13024(B)]
-
578 PE
PE Anti-Choline Acetyltransferase antibody [EPR13024(B)]
Reactivity data
Product details
Product Specifications
Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-Fr, IHC-P, IP, WB in human, mouse, rat samples.
Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) specifically detects Choline Acetyltransferase (UniProt ID: P28329; Molecular weight: 83kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL).
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-Choline Acetyltransferase antibody [EPR13024(B)] (ab181023) has been cited over 23 times in peer reviewed journals and is trusted by the scientific community.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR13024(B) - ab224267.
Antibody clone EPR13024(B) is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, PE, APC, Alexa Fluor® 568 (ab192465, ab192466, ab224000, ab224001, ab302805).
Target Information
Choline Acetyltransferase (ChAT) is an enzyme responsible for the synthesis of the neurotransmitter acetylcholine, which is crucial for cholinergic neurotransmission in the nervous system. It is widely used as a marker for cholinergic neurons. Dysregulation of ChAT activity is associated with various neurological disorders, including Alzheimer's disease (AD), where a decrease in acetylcholine levels contributes to cognitive decline, and myasthenia gravis, an autoimmune disorder affecting neuromuscular transmission.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme plays an important role in cholinergic conduction by producing acetylcholine which functions in synaptic transmission. It does not function as part of a larger complex but its activity directly influences cholinergic synapses. Choline acetyltransferase function ensures the synthesis and availability of acetylcholine for release into the synaptic cleft initiating muscle contraction and modulating activity in the central nervous system.
Pathways
Choline acetyltransferase is critical in pathways governing neurotransmitter release such as the cholinergic synapse pathway. It interacts functionally with other proteins within this pathway including acetylcholinesterase which breaks down acetylcholine in the synaptic cleft. This interaction ensures proper neurotransmitter regulation and recycling maintaining synapse function and communication within neuronal circuits.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (46)
Recent publications for all applications. Explore the full list and refine your search
iScience 28:113489 PubMed41019369
2025
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 6:103975 PubMed40711874
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40649809
2025
Applications
Unspecified application
Species
Unspecified reactive species
IBRO neuroscience reports 18:814-822 PubMed40510288
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 15: PubMed40427530
2025
Applications
Unspecified application
Species
Unspecified reactive species
Aging and disease : PubMed40354376
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:98 PubMed40075110
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 23:73 PubMed39815264
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cardiovascular disorders 24:605 PubMed39472780
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 15:1411642 PubMed39139632
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com